-

2020 Guide to European CLP Regulations of Nicotine-Containing Products - Modern Oral Admixtures, Heated Tobacco/e-Cigarette Hybrids and More - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "A Guide to European CLP Regulations" report has been added to ResearchAndMarkets.com's offering.

In Europe, chemical substances are classified according to their toxicity levels. Any that are concluded to be potentially harmful are subject to rules on packaging and labelling.

This report does not aim to provide guidance on every regulation that may apply in all member states of the European Union, rather it will concentrate on an important piece of regulation that may apply to nicotine-containing products such as modern oral admixtures and heated tobacco/e-cigarette hybrids.

CLP regulation is vital to be aware of when placing products on the market, and so a good understanding of this piece of regulation is vital. This bundle report of three individual reports will provide you with a comprehensive overview of the rules within this specific regulation.

Key Topics Covered

Report 1

1 Executive summary

2 Introduction

3 General obligations

4 Assessing the toxicity of nicotine mixtures

5 Rules on warning labels

6 General packaging rules (Article 35)

Report 2

1 Executive summary

2 Introduction

3 General obligation to notify to the C&L Inventory (articles 39-42)

4 Notification to national poison centres (Article 45)

5 A new obligation related to packaging

Report 3

1 Executive summary

2 Introduction

3 Small packaging exception

4 Condition 1: hazard classification

5 Condition 2: shape and form of packaging

6 Condition 3: alternative means of labelling

7 Permissible omission of elements

For more information about this report visit https://www.researchandmarkets.com/r/wsga5h

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Research and Markets


Release Versions

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

More News From Research and Markets

UAE Automotive Spare Parts E-Commerce Market Size, Share, Growth Drivers, Trends, Opportunities, Competitive Landscape & Forecast 2025-2030 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "UAE Automotive Spare Parts E-Commerce Market Size, Share, Growth Drivers, Trends, Opportunities, Competitive Landscape & Forecast 2025-2030" has been added to ResearchAndMarkets.com's offering. The UAE automotive spare parts e-commerce market, valued at USD 1.2 billion, is experiencing a robust expansion influenced by the surge in online shopping, vehicle ownership, and the need for cost-effective solutions. The convenience provided by e-commerce platforms is r...

Non-Opioid Therapeutics Market Insights, Shares and Growth Outlook 2025-2032: Rising Integration of Non-Opioid Options in Multimodal Pain Management Protocols - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Non-Opioid Therapeutics Market - Global Forecast 2025-2032" has been added to ResearchAndMarkets.com's offering. This market research report focuses on the evolving landscape of the Non-Opioid Therapeutics Market. This sector has grown from USD 40.77 billion in 2024 to USD 43.78 billion in 2025, with projections suggesting a CAGR of 7.68% leading to a valuation of USD 73.72 billion by 2032. Non-opioid therapeutics have become critical in modern pain management, add...

Disulfiram Market Report 2025-2032: Growth Forecast, Segment Shares, FPNV Positioning Matrix and More - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Disulfiram Market - Global Forecast 2025-2032" report has been added to ResearchAndMarkets.com's offering. The Disulfiram Market is advancing in scope and strategic significance as evolving clinical practices, regulatory shifts, and technology continue to reframe substance use disorder management. Senior executives must navigate opportunities and risks shaped by global healthcare transformation, positioning their organizations for competitive relevance. Market Snap...
Back to Newsroom